Dr Shahin Lockman

Dr Lockman is an infectious-disease trained clinician and has led clinical investigation related to HIV in collaboration with colleagues in Botswana since 1996. One of her research focus areas is the safety and efficacy of antiretroviral drugs used for HIV treatment and prevention among pregnant and postpartum women, including through clinical trials in pregnancy and studies of neurodevelopment of antiretroviral-exposed children.

Dr Lockman mentors early-stage investigators on a range of clinical research projects in Botswana. She is joint PI of the Botswana Clinical Trials Unit at the Botswana Harvard AIDS Institute Partnership (conducting ACTG, IMPAACT, and HPTN network trials), and co-chairs workshops and a working group led by the World Health Organization that focuses on accelerating ethical research of new HIV agents during pregnancy and breastfeeding.